An aryl hydrocarbon receptor odyssey to the shores of toxicology: The Deichmann Lecture, International Congress of Toxicology-XI

Toxicological Sciences

Volumn 98, Issue 1, 2007, Pages 5-38

  Okey, Allan B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Dioxin; Gene regulation

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; ARACHIDONIC ACID; AROMATIC HYDROCARBON RECEPTOR; ASPARTATE AMINOTRANSFERASE; BENZ[A]ANTHRACENE; BENZO[A]PYRENE; BILIRUBIN; CH 223191; CHLORPHENOTANE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DIBENZOFURAN DERIVATIVE; DIMETHYLBENZ[A]ANTHRACENE; DIOXIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; OMEPRAZOLE; POLYCHLORINATED BIPHENYL; RECEPTOR BLOCKING AGENT; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CARCINOGENICITY; CHLORACNE; COMPLEX FORMATION; DRUG MECHANISM; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE STRUCTURE; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; NONHUMAN; ONTOGENY; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RECEPTOR BINDING; RISK ASSESSMENT; SPECIES DIFFERENCE; TERATOGENICITY; TISSUE SPECIFICITY; TOXICOKINETICS;

ANIMALS; ENVIRONMENTAL POLLUTANTS; ESTROGENS; HUMANS; POLYCYCLIC HYDROCARBONS, AROMATIC; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

ANIMALIA;

EID: 34447530842     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfm096     Document Type: Article

References (327)

1. Abdelrahim, M., Ariazi, E., Kim, K., Khan, S., Barhoumi, R., Burghardt, R., Liu, S., Hill, D., Finnell, R., Wlodarczyk, B., et al. (2006). 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha. Cancer Res. 66, 2459-2467.
2. Anttila, S., Lei, X. D., Elovaara, E., Karjalainen, A., Sun, W., Vainio, H., and Hankinson, O. (2000). An uncommon phenotype of poor inducibility of CYP1A1 in human lung is not ascribable to polymorphisms in the AHR, ARNT, or CYP1A1 genes. Pharmacogenetics 10, 741-751.
3. Anttila, S., Tuominen, P., Hirvonen, A., Nurminen, M., Karjalainen, A., Hankinson, O., and Elovaara, E. (2001). CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 11, 501-509.
4. Baba, T., Mimura, J., Nakamura, N., Harada, N., Yamamoto, M., Morohashi, K., and Fujii-Kuriyama, Y. (2005). Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. Mol. Cell. Biol. 25, 10040-10051.
5. Bandiera, S., Safe, S., and Okey, A. B. (1982). Binding of polychlorinated biphenyls classified as either phenobarbitone-, 3-methylcholanthrene- or mixed-type inducers to cytosolic Ah receptor. Chem. Biol. Interact. 39, 259-277.
6. Beischlag, T. V., and Perdew, G. H. (2005). ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. J. Biol. Chem. 280, 21607-21611.
7. Belous, A. R., Hachey, D. L., Dawling, S., Roodi, N., and Parl, F. F. (2007). Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res. 67 812-817.
8. Berwick, M., Matullo, G., Song, Y. S., Guarrera, S., Dominguez, G., Orlow, I., Walker, M., and Vineis, P. (2004). Association between aryl hydrocarbon receptor genotype and survival in soft tissue sarcoma. J. Clin. Oncol. 22, 3997-4001.
9. Bhat, R., and Bresnick, E. (1997). Glycine N-methyltransferase is an example of functional diversity. Role as a polycyclic aromatic hydrocarbon-binding receptor. J. Biol. Chem. 272, 21221-21226.
10. Bitman, J., Cecil, H. C., Harris, S. J., and Fries, G. F. (1968). Estrogenic activity of o,p′-DDT in the mammalian uterus and avian oviduct. Science 162, 371-372.
11. Bittinger, M. A., Nguyen, L. P., and Bradfield, C. A. (2003). Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor. Mol. Pharmacol. 64, 550-556.
12. Bock, K. W., and Kohle, C. (2005). Ah receptor- and TCDD-mediated liver tumor promotion: Clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem. Pharmacol. 69, 1403-1408.
13. Bock, K. W., and Kohle, C. (2006). Ah receptor: Dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 72, 393-404.
14. Boutros, P. C., Moffat, I. D., Franc, M. A., Tijet, N., Tuomisto, J., Pohjanvirta, R., and Okey, A. B. (2004). Dioxin-responsive AHRE-II gene battery: Identification by phylogenetic footprinting. Biochem. Biophys. Res. Commun. 321, 707-715.
15. Boverhof, D. R., Burgoon, L. D., Tashiro, C., Chittim, B., Harkema, J. R., Jump, D. B., and Zacharewski, T. R. (2005). Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-mediated hepatotoxicity. Toxicol. Sci. 85 1048-1063.
16. Boverhof, D. R., Burgoon, L. D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J. R., Mendrick, D. L., and Zacharewski, T. R. (2006a). Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci. 94, 398-416.
17. Boverhof, D. R., Kwekel, J. C., Humes, D. G., Burgoon, L. D., and Zacharewski, T. R. (2006b). Dioxin induces an estrogen-like, estrogen receptor-dependent gene expression response in the murine uterus. Mol. Pharmacol. 69, 1599-1606.
18. Bradfield, C. A., Glover, E., and Poland, A. (1991). Purification and N-terminal amino acid sequence of the Ah receptor from the C57BL/6J mouse. Mol. Pharmacol. 39, 13-19.
19. Brauze, D. (2004). Comparison of the induction of a 4S beta-naphthoflavone-binding protein, cytochrome P450 1A1 and NAD(P)H:qUinone oxidoreductase in beta-naphthoflavone-treated rats. Toxicol. Lett. 152, 111-116.
20. Brauze, D., and Malejka-Giganti, D. (2000). A novel 4 S [3H]beta-naphtho-flavone-binding protein in liver cytosol of female Sprague-Dawley rats treated with aryl hydrocarbon receptor agonists. Biochem. J. 347(Pt 3), 787-795.
21. Brunnberg, S., Andersson, P., Lindstam, M., Paulson, I., Poellinger, L., and Hanberg, A. (2006). The constitutively active Ah receptor (CA-Ahr) mouse as a potential model for dioxin exposure - effects in vital organs. Toxicology 224, 191-201.
22. Brunnberg, S., Pettersson, K., Rydin, E., Matthews, J., Hanberg, A., and Pongratz, I. (2003). The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc. Natl. Acad. Sci. U. S. A. 100, 6517-6522.
23. Budinsky,R. A., Paustenbach, D., Fontaine, D., Landenberger, B., and Starr,T.B. (2006). Recommended relative potency factors for 2,3,4,7,8-pentachlorodibenzofuran: The impact of different dose metrics. Toxicol. Sci. 91, 275-285.
24. Bunger,M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., and Bradfield, C. A. (2003). Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J. Biol. Chem. 278 17767-17774.
25. Burbach, K. M., Poland, A., and Bradfield, C. A. (1992). Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. U. S. A. 89, 8185-8189.
26. Carlstedt-Duke, J., Elfstrom, G., Snochowski, M., Hogberg, B., and Gustaffson, J. A. (1978). Detection of the 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) receptor in rat liver by isoelectric focusing in polyacrylamide gels. Toxicol. Lett. 2, 365-373.
27. Carlstedt-Duke, J. M., Elfstrom, G., Hogberg, B., and Gustafsson, J. A. (1979). Ontogeny of the rat hepatic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin and its endocrine independence. Cancer Res. 39, 4653-4656.
28. Cauchi, S., Stucker, I., Solas, C., Laurent-Puig, P., Cenee, S., Hemon, D., Jacquet, M., Kremers, P., Beaune, P., and Massaad-Massade, L. (2001). Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: Relationship with CYP1A1 inducibility and lung cancer. Carcinogenesis 22, 1819-1824.
29. Chen, S., Operana, T., Bonzo, J., Nguyen, N., and Tukey, R. H. (2005). ERK kinase inhibition stabilizes the aryl hydrocarbon receptor: Implications for transcriptional activation and protein degradation. J. Biol. Chem. 280, 4350-4359.
30. Chen, Y., Bai, Y., Yuan, J., Chen, W., Sun, J., Wang, H., Liang, H., Guo, L., Yang, X., Tan, H., et al. (2006). Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 15, 1703-1707.
31. Choi, S. S., Miller,M. A., and Harper, P. A. (2006). In utero exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin induces amphiregulin gene expression in the developing mouse ureter. Toxicol. Sci. 94, 163-174.
32. Clement, J. G., and Okey, A. B. (1972). Estrogenic and anti-estrogenic effects of DDT administered in the diet to immature female rats. Can. J. Physiol. Pharmacol. 50, 971-975.
33. Cole, P., Trichopoulos, D., Pastides, H., Starr, T., and Mandel, J. S. (2003). Dioxin and cancer: A critical review. Regul. Toxicol. Pharmacol. 38, 378-388.
34. Conney, A. H. (2003a). Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: The Seventh DeWitt S. Goodman Lecture. Cancer Res. 63, 7005-7031.
35. Conney, A. H. (2003b). Induction of drug-metabolizing enzymes: A path to the discovery of multiple cytochromes P450. Annu. Rev. Pharmacol. Toxicol. 43, 1-30.
36. Connor, K. T., and Aylward, L. L. (2006). Human response to dioxin: Aryl hydrocarbon receptor (AHR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. J. Toxicol. Environ. Health B Crit. Rev. 9, 147-171.
37. Conolly, R. B. (2002). The use of biologically based modeling in risk assessment. Toxicology 181-182, 275-279.
38. Coumoul, X., Diry, M., and Barouki, R. (2002). PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides. Biochem. Pharmacol. 64, 1513-1519.
39. Dao, T. L., and Sunderland, H. (1959). Mammary carcinogenesis by 3-methylcholanthrene. I. Hormonal aspects in tumor induction and growth. J. Natl. Cancer Inst. 23, 567-585.
40. 3H]methylcholanthrene and formation of a 165-kDa complex between the ligand-binding subunit and a novel cytosolic protein. J. Biol. Chem. 269, 12129-12136.
41. Denison, M. S., Fisher, J. M., and Whitlock, J. P., Jr. (1988a). Inducible, receptor-dependent protein-DNA interactions at a dioxinresponsive transcriptional enhancer. Proc. Natl. Acad. Sci. U. S. A. 85, 2528-2532.
42. Denison, M. S., Fisher, J. M., and Whitlock, J. P., Jr., (1988b). The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. J. Biol. Chem. 263, 17221-17224.
43. Denison, M. S., Hamilton, J. W., and Wilkinson, C. F. (1985). Comparative studies of aryl hydrocarbon hydroxylase and the Ah receptor in non-mammalian species. Comp. Biochem. Physiol. C 80, 319-324.
44. Denison, M. S., and Nagy, S. R. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334.
45. Denison, M. S., Okey, A. B., Hamilton, J.W., Bloom, S. E., andWilkinson, C. F. (1986a). Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin: Ontogeny in chick embryo liver. J. Biochem. Toxicol. 1, 39-49.
46. Denison, M. S., Pandini, A., Nagy, S. R., Baldwin, E. P., and Bonati, L. (2002). Ligand binding and activation of the Ah receptor. Chem. Biol. Interact. 141, 3-24.
47. Denison, M. S., Vella, L. M., and Okey, A. B. (1986b). Hepatic Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Partial stabilization by molybdate. J. Biol. Chem. 261, 10189-10195.
48. Denison, M. S., Vella, L. M., and Okey, A. B. (1986c). Structure and function of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Species difference in molecular properties of the receptors from mouse and rat hepatic cytosols. J. Biol. Chem. 261, 3987-3995.
49. Denison, M. S., and Wilkinson, C. F. (1985). Identification of the Ah receptor in selected mammalian species and induction of aryl hydrocarbon hydroxylase. Eur. J. Biochem. 147, 429-435.
50. Denison, M. S., Wilkinson, C. F., and Okey, A. B. (1986d). Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin: Comparative studies in mammalian and non-mammalian species. Chemosphere 15, 1665-1672.
51. Dodds, E. C., Goldberg, L., Lawson, W., and Robinson, R. (1938). Estrogenic activity of certain synthetic compounds. Nature 141 247-248.
52. Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., and Bradfield, C. A. (1993). Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 44, 911-917.
53. Dunham, E. E., Stevens, E. A., Glover, E., and Bradfield, C. A. (2006). The aryl hydrocarbon receptor signaling pathway is modified through interactions with a Kelch protein. Mol. Pharmacol. 70, 8-15.
54. Elferink, C. J., Gasiewicz, T. A., and Whitlock, J. P., Jr. (1990). Protein-DNA interactions at a dioxin-responsive enhancer. Evidence that the transformed Ah receptor is heteromeric. J. Biol. Chem. 265 20708-20712.
55. Elferink, C. J., and Whitlock, J. P., Jr. (1994). Dioxin-dependent, DNA sequence-specific binding of a multiprotein complex containing the Ah receptor. Receptor 4, 157-173.
56. Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., and Fujii-Kuriyama, Y. (1994). Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J. Biol. Chem. 269, 27337-27343.
57. Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., Funae, Y., and Fujii-Kuriyama, Y. (1992). cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184, 246-253.
58. Evans, R. (2004). A transcriptional basis for physiology. Nat. Med. 10, 1022-1026.
59. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor (see comments). Science 268, 722-726.
60. Fletcher, N., Wahlstrom, D., Lundberg, R., Nilsson, C. B., Nilsson, K. C., Stockling, K., Hellmold, H., and Hakansson, H. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: A microarray study. Toxicol. Appl. Pharmacol. 207, 1-24.
61. Franc, M. A., Pohjanvirta, R., Tuomisto, J., and Okey, A. B. (2001a). In vivo up-regulation of aryl hydrocarbon receptor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in a dioxin-resistant rat model. Biochem. Pharmacol. 62, 1565-1578.
62. Franc, M. A., Pohjanvirta, R., Tuomisto, J., and Okey, A. B. (2001b). Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: Effect on aryl hydrocarbon receptor expression in a dioxin-resistance model. Toxicol. Appl. Pharmacol. 175, 43-53.
63. Fryer, B. H., and Simon, M. C. (2006). Hypoxia, HIF and the placenta. Cell Cycle 5, 495-498.
64. Fujisawa-Sehara, A., Yamane, M., and Fujii-Kuriyama, Y. (1988). A DNA-binding factor specific for xenobiotic responsive elements of P-450c gene exists as a cryptic form in cytoplasm: Its possible translocation to nucleus. Proc. Natl. Acad. Sci. U. S. A. 85, 5859-5863.
65. Fujita, H., Kosaki, R., Yoshihashi, H., Ogata, T., Tomita, M., Hasegawa, T., Takahashi, T., Matsuo, N., and Kosaki, K. (2002). Characterization of the aryl hydrocarbon receptor repressor gene and association of its Pro185Ala polymorphism with micropenis. Teratology 65, 10-18.
66. Fukunaga, B. N., Probst, M. R., Reisz-Porszasz, S., and Hankinson, O. (1995). Identification of functional domains of the aryl hydrocarbon receptor. J. Biol. Chem. 270, 29270-29278.
67. Gambier, N., Marteau, J. B., Batt, A. M., Marie, B., Thompson, A., Siest, G., Foernzler, D., and Visvikis-Siest, S. (2006). Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort. J. Hypertens. 24, 2199-2205.
68. Gasiewicz, T. A., and Bauman, P. A. (1987). Heterogeneity of the rat hepatic Ah receptor and evidence for transformation in vitro and in vivo. J. Biol. Chem. 262, 2116-2120.
69. Gasiewicz, T. A., Elferink, C. J., and Henry, E. C. (1991). Characterization of multiple forms of the Ah receptor: Recognition of a dioxin-responsive enhancer involves heteromer formation. Biochemistry 30, 2909-2916.
70. Gasiewicz, T. A., and Neal, R. A. (1982). The examination and quantitation of tissue cytosolic receptors for 2,3,7,8-tetrachlorodibenzo-p-dioxin using hydroxylapatite. Anal. Biochem. 124, 1-11.
71. Gasiewicz, T. A., Ness,W. C., and Rucci, G. (1984). Ontogeny of the cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver, lung, and thymus. Biochem. Biophys. Res. Commun. 118, 183-190.
72. Gasiewicz, T. A., and Rucci, G. (1984). Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Evidence for a homologous nature among various mammalian species. Mol. Pharmacol. 26, 90-98.
73. Gass, G. H., Brown, J., and Okey, A. B. (1974). Carcinogenic effects of oral diethylstilbestrol on C3H male mice with and without the mammary tumor virus. J. Natl. Cancer Inst. 53, 1369-1370.
74. Geusau, A., Abraham, K., Geissler, K., Sator, M. O., Stingl, G., and Tschachler, E. (2001). Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Clinical and laboratory effects. Environ. Health Perspect. 109, 865-869.
75. Giannone, J. V., Li, W., Probst, M., and Okey, A. B. (1998). Prolonged depletion of AH receptor without alteration of receptor mRNA levels after treatment of cells in culture with 2,3,7,8-tetrachlorodibenzo-p dioxin. Biochem. Pharmacol. 55, 489-497.
76. Giannone, J. V., Okey, A. B., and Harper, P. A. (1995). Characterization of polyclonal antibodies to the aromatic hydrocarbon receptor. Can. J. Physiol. Pharmacol. 73, 7-17.
77. Giguere, V. (1999). Orphan nuclear receptors: From gene to function. Endocr. Rev. 20, 689-725.
78. Golas, C. L., Prokipcak, R. D., Okey, A. B., Manchester, D. K., Safe, S., and Fujita, T. (1990). Competitive binding of 7-substituted-2,3-dichlorodibenzo-p-dioxins with human placental ah receptor - a QSAR analysis. Biochem. Pharmacol. 40, 737-741.
79. Gough, M. (2003). The limits of science: Dioxin. Regul. Toxicol. Pharmacol. 37, 170-171.
80. Greenlee, W. F., and Poland, A. (1979). Nuclear uptake of 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice. Role of the hepatic cytosol receptor protein. J. Biol. Chem. 254, 9814-9821.
81. Gu, Y. Z., Hogenesch, J. B., and Bradfield, C. A. (2000). The PAS superfamily: Sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40, 519-561.
82. Gunton, J. E., Kulkarni, R. N., Yim, S., Okada, T., Hawthorne, W. J., Tseng, Y. H., Roberson, R. S., Ricordi, C., O'Connell, P. J., Gonzalez, F. J., et al. (2005). Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122, 337-349.
83. Guo, J., Sartor, M., Karyala, S., Medvedovic, M., Kann, S., Puga, A., Ryan, P., and Tomlinson, C. R. (2004). Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice. Toxicol. Appl. Pharmacol. 194, 79-89.
84. Gustafsson, J. A. (1999). Seeking ligands for lonely orphan receptors. Science 284, 1285-1286.
85. Guzelian, P., Quattrochi, L., Karch, N., Aylward, L., and Kaley, R. (2006). Does dioxin exert toxic effects in humans at or near current background body levels?: An evidence-based conclusion. Hum. Exp. Toxicol. 25, 99-105.
86. Haag-Gronlund,M., Johansson,N., Fransson-Steen,R.,Hakansson,H., Scheu,G., and Warngard, L. (1998). Interactive effects of three structurally different polychlorinated biphenyls in a rat liver tumor promotion bioassay. Toxicol. Appl. Pharmacol. 152, 153-165.
87. Hahn, M. E. (1998). The aryl hydrocarbon receptor: A comparative perspective. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 121, 23-53.
88. Hahn, M. E. (2002). Aryl hydrocarbon receptors: Diversity and evolution. Chem. Biol. Interact. 141, 131-160.
89. Hahn, M. E., Karchner, S. I., Evans, B. R., Franks, D. G., Merson, R. R., and Lapseritis, J. M. (2006). Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: Insights from comparative genomics. J. Exp. Zool. A Comp Exp. Biol. 305, 693-706.
90. Hahn, M. E., Poland, A., Glover, E., and Stegeman, J. J. (1994). Photoaffinity labeling of the Ah receptor: Phylogenetic survey of diverse vertebrate and invertebrate species. Arch. Biochem. Biophys. 310, 218-228.
91. Hamilton, J. W., Denison, M. S., and Bloom, S. E. (1983). Development of basal and induced aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity in the chicken embryo in ovo. Proc. Natl. Acad. Sci. U. S. A. 80, 3372-3376.
92. Hankinson, O. (1979). Single-step selection of clones of a mouse hepatoma line deficient in aryl hydrocarbon hydroxylase. Proc. Natl. Acad. Sci. U. S. A. 76, 373-376.
93. Hankinson, O. (2005). Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch. Biochem. Biophys. 433 379-386.
94. Harper, P. A., Giannone, J. V., Okey, A. B., and Denison, M. S. (1992). In vitro transformation of the human Ah receptor and its binding to a dioxin response element. Mol. Pharmacol. 42, 603-612.
95. Harper, P. A., Golas, C. L., and Okey, A. B. (1988). Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and benz(a)anthracene in the human A431 squamous cell carcinoma line. Cancer Res. 48, 2388-2395.
96. Harper, P. A., Golas, C. L., and Okey, A. B. (1991a). Ah receptor in mice genetically "nonresponsive" for cytochrome P4501A1 induction: Cytosolic Ah receptor, transformation to the nuclear binding state, and induction of aryl hydrocarbon hydroxylase by halogenated and nonhalogenated aromatic hydrocarbons in embryonic tissues and cells. Mol. Pharmacol. 40, 818-826.
97. Harper, P. A., Prokipcak, R. D., Bush, L. E., Golas, C. L., and Okey, A. B. (1991b). Detection and characterization of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human colon adenocarcinoma cell line LS180. Arch. Biochem. Biophys. 290, 27-36.
98. Harper, P. A., Riddick, D. S., and Okey, A. B. (2006). Regulating the regulator: Factors that control levels and activity of the aryl hydrocarbon receptor. Biochem. Pharmacol. 72, 267-279.
99. Harper, P. A.,Wong, J. Y., Lam, M. S., and Okey, A. B. (2002). Polymorphisms in the human AH receptor. Chem. Biol. Interact. 141, 161-187.
100. Harris, M., Kamps, C., and Safe, S. (1988). Role of the 4-5S binding protein in the induction of aryl hydrocarbon hydroxylase in the rat. Carcinogenesis 9, 1475-1479.
101. Haws, L. C., Su, S. H., Harris, M., Devito, M. J., Walker, N. J., Farland, W. H., Finley, B., and Birnbaum, L. S. (2006). Development of a refined database of mammalian relative potency estimates for dioxin-like compounds. Toxicol. Sci. 89, 4-30.
102. Henry, E. C., Bemis, J. C., Henry, O., Kende, A. S., and Gasiewicz, T. A. (2006). A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch. Biochem. Biophys. 450, 67-77.
103. Henry, E. C., and Gasiewicz, T. A. (2003). Agonist but not antagonist ligands induce conformational change in the mouse aryl hydrocarbon receptor as detected by partial proteolysis. Mol. Pharmacol. 63 392-400.
104. Henry, E. C., Kende, A. S., Rucci, G., Totleben, M. J., Willey, J. J., Dertinger, S. D., Pollenz, R. S., Jones, J. P., and Gasiewicz, T. A. (1999). Flavone antagonists bind competitively with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. Mol. Pharmacol. 55, 716-725.
105. Herbst, A. L., Ulfelder, H., and Poskanzer, D. C. (1971). Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284, 878-881.
106. Hestermann, E. V., Stegeman, J. J., and Hahn, M. E. (2000). Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol. Appl. Pharmacol. 168, 160-172.
107. Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252, 954-958.
108. Hu, W., Sorrentino, C., Denison, M. S., Kolaja, K., and Fielden, M. R. (2007). Induction of Cyp1a1 is a non-specific biomarker of aryl hydrocarbon receptor activation: Results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol. Pharmacol. doi: 10.1124/mol.106.032748.
109. Huang, G., and Elferink, C. J. (2005). Multiple mechanisms are involved in Ah receptor-mediated cell cycle arrest. Mol. Pharmacol. 67 88-96.
110. Huang, Y., Harper, P. A., and Okey, A. B. (1995). Aromatic hydrocarbon receptor in cultured fetal cells from C57BL/6J and DBA/2J mice: Similarity in molecular mass to receptors in adult livers. Can. J. Physiol. Pharmacol. 73, 18-26.
111. Huggins, C., Grand, L. C., and Brillantes, F. P. (1961). Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression. Nature 189, 204-207.
112. Ianicello, C. M., and Okey, A. B. (1976). In vivo and in vitro effects of dimethylbenz(a)anthracene on nuclear uptake of estrogen-receptor complex in rat uterus. Oncology 33, 225-228.
113. Ikuta, T., Eguchi, H., Tachibana, T., Yoneda, Y., and Kawajiri, K. (1998). Nuclear localization and export signals of the human aryl hydrocarbon receptor. J. Biol. Chem. 273, 2895-2904.
114. Ikuta, T., Kobayashi, Y., and Kawajiri, K. (2004a). Cell density regulates intracellular localization of aryl hydrocarbon receptor. J. Biol. Chem. 279, 19209-19216.
115. Ikuta, T., Kobayashi, Y., and Kawajiri, K. (2004b). Phosphorylation of nuclear localization signal inhibits the ligand-dependent nuclear import of aryl hydrocarbon receptor. Biochem. Biophys. Res. Commun. 317, 545-550.
116. Jensen, E. V. (2004). From chemical warfare to breast cancer management. Nat. Med. 10, 1018-1021.
117. Kahl, G. F., Friederici, D. E., Bigelow, S. W., Okey, A. B., and Nebert, D. W. (1980). Ontogenetic expression of regulatory and structural gene products associated with the Ah locus. Comparison of rat, mouse, rabbit and Sigmoden hispedis. Dev. Pharmacol. Ther. 1, 137-162.
118. Kalow, W. (1962). Pharmacogenetics: Heredity and the Response to Drugs. W.B. Saunders, Philadelphia.
119. Kamps, C., and Safe, S. (1987). Binding of polynuclear aromatic hydrocarbons to the rat 4S cytosolic binding protein: Structure-activity relationships. Cancer Lett. 34, 129-137.
120. Karchner, S. I., Franks, D. G., Kennedy, S. W., and Hahn, M. E. (2006). The molecular basis for differential dioxin sensitivity in birds: Role of the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 103, 6252-6257.
121. Karyala, S., Guo, J., Sartor, M., Medvedovic, M., Kann, S., Puga, A., Ryan, P., and Tomlinson, C. R. (2004). Different global gene expression profiles in benzo[a]pyrene- and dioxin-treated vascular smooth muscle cells of AHR-knockout and wild-type mice. Cardiovasc. Toxicol. 4, 47-74.
122. Kawajiri, K.,Watanabe, J., Eguchi, H.,Nakachi, K., Kiyohara, C., and Hayashi, S. (1995). Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 5, 151-158.
123. Keightley, D. D., and Okey, A. B. (1973). Effects of dimethylbenz(a)anthracene and dihydrotestosterone on estradiol-17 beta binding in rat mammary cytosol fraction. Cancer Res. 33, 2637-2642.
124. Keightley, D. D., and Okey, A. B. (1974). Effect of a carcinogenic oral dose of 7,12-dimethylbenz(a)anthracene on receptor binding of estradiol-17 beta in uterus and mammary tissue throughout lactation in the rat. Cancer Res. 34, 609-612.
125. Kewley, R. J., Whitelaw, M. L., and Chapman-Smith, A. (2004). The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell. Biol. 36, 189-204.
126. Khan, S., Konstantinov, A., Chittim, B., McAlees, A., Yeo, B., and Safe, S. (2006). Structure-dependent Ah receptor agonist activities of chlorinated biphenylenes. Toxicol. In Vitro 20, 1234-1237.
127. Kietz, S., Thomsen, J. S., Matthews, J., Pettersson, K., Strom, A., and Gustafsson, J. A. (2004). The Ah receptor inhibits estrogen-induced estrogen receptor beta in breast cancer cells. Biochem. Biophys. Res. Commun. 320, 76-82.
128. Kim, J. H., Kim, H., Lee, K. Y., Kang, J.W., Lee, K. H., Park, S. Y., Yoon, H. I., Jheon, S. H., Sung, S. W., and Hong, Y. C. (2007a). Aryl hydrocarbon receptor gene polymorphisms affect lung cancer risk. Lung Cancer. 56, 9-15.
129. Kim, S. H.,Henry,E. C.,Kim,D.K., Kim,Y. H., Shin, K. J.,Han,M.S., Lee,T. G., Kang, J. K., Gasiewicz, T. A., Ryu, S. H., et al. (2006b). Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol. Pharmacol. 69, 1871-1878.
130. Kliewer, S. A., Lehmann, J. M., and Willson, T. M. (1999). Orphan nuclear receptors: Shifting endocrinology into reverse. Science 284, 757-760.
131. Ko, H. P., Okino, S. T., Ma, Q., and Whitlock, J. P., Jr. (1997). Transactivation domains facilitate promoter occupancy for the dioxin-inducible CYP1A1 gene in vivo. Mol. Cell. Biol. 17, 3497-3507.
132. Kohle, C., Hassepass, I., Bock-Hennig, B. S., Walter Bock, K., Poellinger, L., and McGuire, J. (2002). Conditional expression of a constitutively active aryl hydrocarbon receptor in MCF-7 human breast cancer cells. Arch. Biochem. Biophys. 402, 172-179.
133. Korkalainen, M., Tuomisto, J., and Pohjanvirta, R. (2000). Restructured transactivation domain in hamster AH receptor. Biochem. Biophys. Res. Commun. 273, 272-281.
134. Korkalainen, M., Tuomisto, J., and Pohjanvirta, R. (2001). The AH receptor of the most dioxin-sensitive species, guinea pig, is highly homologous to the human AH receptor. Biochem. Biophys. Res. Commun. 285, 1121-1129.
135. Koyano, S., Saito,Y., Fukushima-Uesaka,H., Ishida, S.,Ozawa, S.,Kamatani, N., Minami, H., Ohtsu, A., Hamaguchi, T., Shirao, K., Yoshida, T., et al. (2005). Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese population. Drug Metab. Dispos. 33, 1254-1260.
136. Kozak, K. R., Abbott, B., and Hankinson, O. (1997). ARNT-deficient mice and placental differentiation. Dev. Biol. 191, 297-305.
137. Lahvis, G. P., and Bradfield, C. A. (1998). Ahr null alleles: Distinctive or different? Biochem. Pharmacol. 56, 781-787.
138. Lahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K., and Bradfield, C. A. (2005). The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol. 67, 714-720.
139. Landers, J. P., Piskorska-Pliszczynska, J., Zacharewski, T., Bunce, N. J., and Safe, S. (1989). Photoaffinity labeling of the nuclear Ah receptor from mouse Hepa 1c1c7 cells using 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 264, 18463-18471.
140. Lee, J. E., and Safe, S. (2000). 3′,4′-Dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol. Sci. 58, 235-242.
141. Lee, K., Burgoon,L. D.,Lamb, L., Dere, E., Zacharewski,T. R., Hogenesch, J. B., and Lapres, J. J. (2006). Identification and characterization of genes susceptible to transcriptional cross-talk between the hypoxia and dioxin signaling cascades. Chem. Res. Toxicol. 19, 1284-1293.
142. Legraverend, C., Hannah, R. R., Eisen, H. J., Owens, I. S., Nebert, D. W., and Hankinson, O. (1982). Regulatory gene product of the Ah locus. Characterization of receptor mutants among mouse hepatoma clones. J. Biol. Chem. 257, 6402-6407.
143. Li, W., Harper, P. A., Tang, B. K., and Okey, A. B. (1998). Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene. Biochem. Pharmacol. 56, 599-612.
144. Liebler, D. C., and Guengerich, F. P. (2005). Elucidating mechanisms of drug-induced toxicity. Nat. Rev. Drug Discov. 4, 410-420.
145. Lin, T. M., Ko, K., Moore, R. W., Buchanan, D. L., Cooke, P. S., and Peterson, R. E. (2001). Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice. J. Toxicol. Environ. Health A 64, 327-342.
146. Liu, S., Abdelrahim, M., Khan, S., Ariazi, E., Jordan, V. C., and Safe, S. (2006). Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. Biol. Chem. 387 1209-1213.
147. Long, J. R., Egan, K. M., Dunning, L., Shu, X. O., Cai, Q., Cai, H., Dai, Q., Holtzman, J., Gao, Y. T., and Zheng, W. (2006). Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet. Genomics 16, 237-243.
148. Lorenzen, A., and Okey, A. B. (1990). Detection and characterization of [3H]2,3,7,8-tetrachlorodibenzo-p-dioxin binding to Ah receptor in a rainbow trout hepatoma cell line. Toxicol. Appl. Pharmacol. 106 53-62.
149. Lorenzen, A., and Okey, A. B. (1991). Detection and characterization of Ah receptor in tissue and cells from human tonsils. Toxicol. Appl. Pharmacol. 107, 203-214.
150. Ma, Q., and Baldwin, K. T. (2000). 2,3,7,8-Tetrachlorodibenzo-p dioxininduced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activation and DNA binding of AhR. J. Biol. Chem. 275, 8432-8438.
151. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., and Simon, M. C. (1997). Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407.
152. Manchester, D. K., Gordon, S. K., Golas, C. L., Roberts, E. A., and Okey, A. B. (1987). Ah receptor in human placenta: Stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo a]pyrene. Cancer Res. 47, 4861-4868.
153. Manchester, D. K., Parker, N. B., and Bowman, C. M. (1984). Maternal smoking increases xenobiotic metabolism in placenta but not umbilical vein endothelium. Pediatr. Res. 18, 1071-1075.
154. Marlowe, J. L., and Puga, A. (2005). Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell. Biochem. 96, 1174-1184.
155. Martinez, J. M., Afshari, C. A., Bushel, P. R., Masuda, A., Takahashi, T., and Walker, N. J. (2002). Differential toxicogenomic responses to
156. Mason, M. E., and Okey, A. B. (1982). Cytosolic and nuclear binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the Ah receptor in extra-hepatic tissues of rats and mice. Eur. J. Biochem. 123 209-215.
157. Matthews, J., and Gustafsson, J. A. (2006). Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl. Recept. Signal. 4, e016.
158. Matthews, J., Wihlen, B., Thomsen, J., and Gustafsson, J. A. (2005). Aryl hydrocarbon receptor-mediated transcription: Ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo- p-dioxin-responsive promoters. Mol. Cell. Biol. 25, 5317-5328.
159. McDearmon, E. L., Patel, K. N., Ko, C. H., Walisser, J. A., Schook, A. C., Chong, J. L., Wilsbacher, L. D., Song, E. J., Hong, H. K., Bradfield, C. A., et al. (2006). Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice. Science 314, 1304-1308.
160. McGuire, J., Okamoto, K., Whitelaw, M. L., Tanaka, H., and Poellinger, L. (2001). Definition of a dioxin receptor mutant that is a constitutive activator of transcription: Delineation of overlapping repression and ligand binding functions within the PAS domain. J. Biol. Chem. 276, 41841-41849.
161. McMillan, B. J., and Bradfield, C. A. (2007). The Aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 104, 1412-1417.
162. Miller, A. G., Israel, D., and Whitlock, J. P., Jr. (1983). Biochemical and genetic analysis of variant mouse hepatoma cells defective in the induction of benzo(a)pyrene-metabolizing enzyme activity. J. Biol.Chem. 258, 3523-3527.
163. Miller, A. G., and Whitlock, J. P., Jr. (1981). Novel variants in benzo(a)pyrene metabolism. Isolation by fluorescence-activated cell sorting. J. Biol. Chem. 256, 2433-2437.
164. Mimura, J., Ema, M., Sogawa, K., Ikawa, S., and Fujii-Kuriyama, Y. (1994). A complete structure of the mouse Ah receptor gene. Pharmacogenetics 4, 349-354.
165. Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., et al. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2, 645-654.
166. Mitchell, K. A., Lockhart, C. A., Huang, G., and Elferink, C. J. (2006). Sustained aryl hydrocarbon receptor activity attenuates liver regeneration. Mol. Pharmacol. 70, 163-170.
167. Moriguchi, T., Motohashi, H., Hosoya, T., Nakajima, O., Takahashi, S., Ohsako, S., Aoki, Y., Nishimura, N., Tohyama, C., Fujii-Kuriyama, Y., et al. (2003). Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc. Natl. Acad. Sci. U. S. A. 100, 5652-5657.
168. Mufti, N. A., and Shuler, M. L. (1996). Possible role of arachidonic acid in stress-induced cytochrome P450IA1 activity. Biotechnol. Prog. 12, 847-854.
169. NatAcadSci. (2006). Health Risks from Dioxin and Related Compounds: Evaluation of the EPA Reassessment. Available at: http://dels.nas.edu/dels/rpt_briefs/dioxin_brief_final.pdf. Accessed February 2007.
170. Nebert, D. W. (1988). The 1986 Bernard B. Brodie award lecture. The genetic regulation of drug-metabolizing enzymes. Drug Metab. Dispos. 16, 1-8.
171. Nebert, D. W. (1989). The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20, 153-174.
172. Nebert, D.W., and Bausserman, L. L. (1970a). Fate of inducer during induction of aryl hydrocarbon hydroxylase activity in mammalian cell culture. II. Levels of intracellular polycyclic hydrocarbon during enzyme induction and decay. Mol. Pharmacol. 6, 304-314.
173. Nebert, D.W., and Bausserman, L. L. (1970b). Genetic differences in the extent of aryl hydrocarbon hydroxylase induction in mouse fetal cell cultures. J. Biol. Chem. 245, 6373-6382.
174. Nebert, D. W., and Dalton, T. P. (2006). The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat. Rev. Cancer 6, 947-960.
175. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279, 23847-23850.
176. Nebert, D. W., Eisen, H. J., Negishi, M., Lang, M. A., Hjelmeland, L. M., and Okey, A. B. (1981). Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities. Annu. Rev. Pharmacol. Toxicol. 21, 431-462.
177. Nebert, D.W., and Gelboin, H. V. (1968a). Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J. Biol. Chem. 243, 6242-6249.
178. Nebert, D.W., and Gelboin, H. V. (1968b). Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. II. Cellular responses during enzyme induction. J. Biol. Chem. 243, 6250-6261.
179. Nebert, D. W., and Gelboin, H. V. (1969). The in vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. Arch. Biochem. Biophys. 134, 76-89.
180. Nebert, D.W., Robinson, J. R., Niwa, A., Kumaki, K., and Poland, A. P. (1975). Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. J. Cell. Physiol. 85, 393-414.
181. Nebert, D.W., Roe, A. L., Dieter,M. Z., Solis,W. A., Yang, Y., and Dalton, T. P. (2000). Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59, 65-85.
182. Nebert, D. W., Winker, J., and Gelboin, H. V. (1969). Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women. Cancer Res. 29, 1763-1769.
183. Nemoto, T., Mason, G. G., Wilhelmsson, A., Cuthill, S., Hapgood, J., Gustafsson, J. A., and Poellinger, L. (1990). Activation of the dioxin and glucocorticoid receptors to a DNA binding state under cell-free conditions. J. Biol. Chem. 265, 2269-2277.
184. Nohara, K., Pan, X., Tsukumo, S., Hida, A., Ito, T., Nagai, H., Inouye, K., Motohashi, H., Yamamoto, M., Fujii-Kuriyama, Y., et al. (2005). Constitutively active aryl hydrocarbon receptor expressed specifically in T-lineage cells causes thymus involution and suppresses the immunization-induced increase in splenocytes. J. Immunol. 174, 2770-2777.
185. Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., et al. (2003). Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423, 545-550.
186. Okey, A. B. (1972). Dimethylbenzanthracene-induced mammary tumors in rats: Inhibition by DDT. Life Sci. I 11, 833-843.
187. Okey, A. B. (1990). Enzyme induction in the cytochrome P-450 system. Pharmacol. Ther. 45, 241-298.
188. Okey, A. B. (2005). Variability in induction of human drug metabolizing enzymes. In Pharmacogenomics (W. Kalow, U. A. Meyer, and R. F. Tyndale, Eds.), pp. 157-205. Taylor & Francis, New York.
189. Okey, A. B., and Bondy, G. P. (1977). Is delta-9-tetrahydrocannabinol estrogenic. Science 195, 904-906.
190. Okey, A. B., and Bondy, G. P. (1978a). delta9-Tetrahydrocannabinol and 17beta-estradiol bind to different macromolecules in estrogen target tissues. Science 200, 312-314.
191. Okey, A. B., and Bondy, G. P. (1978b). Diethylstilbestrol binding to estrogen receptor in mammary tissue and uteri of C3H/HeJ mice. J. Natl. Cancer Inst. 61, 719-724.
192. Okey, A. B., Bondy, G. P., Mason, M. E., Kahl, G. F., Eisen, H. J., Guenthner, T. M., and Nebert, D. W. (1979). Regulatory gene product of the Ah locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation. J. Biol. Chem. 254 11636-11648.
193. Okey, A. B., Bondy, G. P., Mason, M. E., Nebert, D. W., Forster-Gibson, C. J., Muncan, J., and Dufresne, M. J. (1980). Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. J. Biol. Chem. 255, 11415-11422.
194. Okey, A. B., Boutros, P. C., and Harper, P. A. (2005a). Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes. Pharmacogenet. Genomics 15, 371-379.
195. Okey, A. B., Dube, A. W., and Vella, L. M. (1984). Binding of benzo(a)pyrene and dibenz(a,h)anthracene to the Ah receptor in mouse and rat hepatic cytosols. Cancer Res. 44, 1426-1432.
196. Okey, A. B., Franc, M. A., Moffat, I. D., Tijet, N., Boutros, P. C., Korkalainen, M., Tuomisto, J., and Pohjanvirta, R. (2005b). Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: The case of the aryl hydrocarbon receptor. Toxicol. Appl. Pharmacol. 207, S43-S51.
197. Okey, A. B., and Gass, G. H. (1968). Continuous versus cyclic estrogen administration: Mammary carcinoma in C3H mice. J. Natl. Cancer Inst. 40, 225-230.
198. Okey, A. B., Giannone, J. V., Smart, W., Wong, J. M., Manchester, D. K., Parker, N. B., Feeley, M. M., Grant, D. L., and Gilman, A. (1997). Binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to AH receptor in placentas from normal versus abnormal pregnancy outcomes. Chemosphere 34, 1535-1547.
199. Okey, A. B., Riddick, D. S., and Harper, P. A. (1994a). The Ah receptor: Mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70, 1-22.
200. Okey, A. B., Riddick, D. S., and Harper, P. A. (1994b). Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol. Sci. 15, 226-232.
201. Okey, A. B., and Vella, L. M. (1982). Binding of 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin to a common Ah receptor site in mouse and rat hepatic cytosols. Eur. J. Biochem. 127, 39-47.
202. Okey, A. B., and Vella, L. M. (1984). Elevated binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene to the Ah receptor in hepatic cytosols from phenobarbital-treated rats and mice. Biochem. Pharmacol. 33, 531-538.
203. Okey, A. B., Vella, L. M., and Harper, P. A. (1989). Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene. Mol. Pharmacol. 35, 823-830.
204. Ovando, B. J., Vezina, C. M., McGarrigle, B. P., and Olson, J. R. (2006). Hepatic gene downregulation following acute and subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 94, 428-438.
205. Pandini, A., Denison, M. S., Song, Y., Soshilov, A. A., and Bonati, L. (2007). Structural and functional characterization of the aryl hydrocarbon receptor ligand binding domain by homology modeling and mutational analysis. Biochemistry 46, 696-708.
206. Panteleyev, A. A., and Bickers, D. R. (2006). Dioxin-induced chloracne - Reconstructing the cellular and molecular mechanisms of a classic environmental disease. Exp. Dermatol. 15, 705-730.
207. Peakall, D. B. (1967). Pesticide-induced enzyme breakdown of steroids in birds. Nature. 216, 505-506.
208. Perdew, G. H., and Poland, A. (1988). Purification of the Ah receptor from C57BL/6J mouse liver. J. Biol. Chem. 263, 9848-9852.
209. Peters, J. M., Narotsky, M. G., Elizondo, G., Fernandez-Salguero, P. M., Gonzalez, F. J., and Abbott, B. D. (1999). Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice. Toxicol. Sci. 47, 86-92.
210. Petrulis, J. R., and Perdew, G. H. (2002). The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem. Biol. Interact. 141, 25-40.
211. Poellinger, L., Kurl, R. N., Lund, J., Gillner, M., Carlstedt-Duke, J., Hogberg, B., and Gustafsson, J. A. (1982). High-affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin in cell nuclei from rat liver. Biochim. Biophys. Acta 714, 516-523.
212. Poellinger, L., Lund, J., Dahlberg, E., and Gustafsson, J. A. (1985). A hydroxylapatite microassay for receptor binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene in various target tissues. Anal. Biochem. 144, 371-384.
213. Poellinger, L., Lund, J., Gillner, M., Hansson, L. A., and Gustafsson, J. A. (1983). Physicochemical characterization of specific and nonspecific polyaromatic hydrocarbon binders in rat and mouse liver cytosol. J. Biol. Chem. 258, 13535-13542.
214. Pohjanvirta, R. (1990). TCDD resistance is inherited as an autosomal dominant trait in the rat. Toxicol. Lett. 50, 49-56.
215. Pohjanvirta, R., and Tuomisto, J. (1987). Han/Wistar rats are exceptionally resistant to TCDD. II. Arch. Toxicol. Suppl. 11 344-347.
216. Pohjanvirta, R., and Tuomisto, J. (1994). Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: Effects, mechanisms, and animal models. Pharmacol. Rev. 46, 483-549.
217. Pohjanvirta, R., Tuomisto, J., Vartiainen, T., and Rozman, K. (1987). Han/Wistar rats are exceptionally resistant to TCDD. I. Pharmacol. Toxicol. 60, 145-150.
218. Pohjanvirta, R., Wong, J. M. Y., Li, W., Harper, P. A., Tuomisto, J., and Okey, A. B. (1998). Point mutation in intron sequence causes altered carboxylterminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain. Mol. Pharmacol. 54, 86-93.
219. Poland, A. (1997). Reflections on risk assessment of receptor-acting xenobiotics. Regul. Toxicol. Pharmacol. 26, 41-43.
220. Poland, A., Clover, E., Kende, A. S., DeCamp, M., and Giandomenico, C. M. (1976a). 3,4,3′,4′-Tetrachloro azoxybenzene and azobenzene: Potent inducers of aryl hydrocarbon hydroxylase. Science 194 627-630.
221. Poland, A., and Glover, E. (1973a). 2,3,7,8-Tetrachlorodibenzo-p-dioxin: A potent inducer of -aminolevulinic acid synthetase. Science 179, 476-477.
222. Poland, A., and Glover, E. (1973b). Chlorinated dibenzo-p-dioxins: Potent inducers of delta-aminolevulinic acid synthetase and aryl hydrocarbon hydroxylase. II. A study of the structure-activity relationship. Mol. Pharmacol. 9, 736-747.
223. Poland, A., and Glover, E. (1974). Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a potent inducer of aryl hydrocarbon hydroxylase, with 3-methylcholanthrene. Mol. Pharmacol. 10, 349-359.
224. Poland, A., and Glover, E. (1975). Genetic expression of aryl hydrocarbon hydroxylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for a receptor mutation in genetically non-responsive mice. Mol. Pharmacol. 11, 389-398.
225. Poland, A., and Glover, E. (1980). 2,3,7,8,-Tetrachlorodibenzo-p dioxin: Segregation of toxicity with the Ah locus. Mol. Pharmacol. 17, 86-94.
226. Poland, A., and Glover, E. (1987). Variation in the molecular mass of the Ah receptor among vertebrate species and strains of rats. Biochem. Biophys. Res. Commun. 146, 1439-1449.
227. Poland, A., and Glover, E. (1990). Characterization and strain distribution pattern of the murine Ah receptor specified by the Ahd and Ahb-3 alleles. Mol. Pharmacol. 38, 306-312.
228. Poland, A., Glover, E., and Bradfield, C. A. (1991). Characterization of polyclonal antibodies to the Ah receptor prepared by immunization with a synthetic peptide hapten. Mol. Pharmacol. 39, 20-26.
229. Poland, A., Glover, E., Ebetino, F. H., and Kende, A. S. (1986). Photoaffinity labeling of the Ah receptor. J. Biol. Chem. 261 6352-6365.
230. Poland, A., Glover, E., and Kende, A. S. (1976b). Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 251, 4936-4946.
231. Poland, A., and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22 517-554.
232. Poland, A., Palen, D., and Glover, E. (1994). Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 46, 915-921.
233. Poland, A. D. (1996). Meeting report: Receptor-acting xenobiotics and their risk assessment. Drug Metab. Dispos. 24, 1385-1388.
234. Poland, A. P., Glover, E., Robinson, J. R., and Nebert, D. W. (1974). Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1-450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically "nonresponsive to other aromatic hydrocarbons. J. Biol. Chem. 249, 5599-5606.
235. Pollenz, R. S. (2002). The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem. Biol. Interact. 141, 41-61.
236. Pollenz, R. S., Santostefano, M. J., Klett, E., Richardson, V. M., Necela, B., and Birnbaum, L. S. (1998). Female Sprague-Dawley rats exposed to a single oral dose of 2,3,7,8-tetrachlorodibenzo-p dioxin exhibit sustained depletion of aryl hydrocarbon receptor protein in liver, spleen, thymus, and lung. Toxicol. Sci. 42 117-128.
237. Prokipcak, R. D., and Okey, A. B. (1988). Physicochemical characterization of the nuclear form of Ah receptor from mouse hepatoma cells exposed in culture to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys. 267, 811-828.
238. Prokipcak, R. D., and Okey, A. B. (1990). Equivalent molecular mass of cytosolic and nuclear forms of Ah receptor from Hepa-1 cells determined by photoaffinity labeling with 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin. Biochem. Biophys. Res. Commun. 172, 698-704.
239. Prokipcak, R. D., and Okey, A. B. (1991). Downregulation of the Ah receptor in mouse hepatoma cells treated in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Can. J. Physiol. Pharmacol. 69, 1204-1210.
240. Puga, A., Maier, A., and Medvedovic, M. (2000). The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem. Pharmacol. 60, 1129-1142.
241. Puga, A., Xia, Y., and Elferink, C. (2002). Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem. Biol. Interact. 141 117-130.
242. Racky, J., Schmitz, H. J., Kauffmann, H. M., and Schrenk, D. (2004). Single nucleotide polymorphism analysis and functional characterization of the human Ah receptor (AhR) gene promoter. Arch. Biochem. Biophys. 421, 91-98.
243. Raha, A., Joyce, T., Gusky, S., and Bresnick, E. (1995). Glycine N-methyltransferase is a mediator of cytochrome P4501A1 gene expression. Arch. Biochem. Biophys. 322, 395-404.
244. Ramadoss, P., and Perdew, G. H. (2004). Use of 2-azido-3-[125i] [biodo-7,8-dibromodibenzo-p-dioxin as a probe to determine the relative ligand affinity of human versus mouse aryl hydrocarbon receptor in cultured cells. Mol. Pharmacol. 66, 129-136.
245. Rankin, E. B., Higgins, D. F., Walisser, J. A., Johnson, R. S., Bradfield, C. A., and Haase, V. H. (2005). Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Mol. Cell. Biol. 25, 3163-3172.
246. Rannug, A., and Fritsche, E. (2006). The aryl hydrocarbon receptor and light. Biol. Chem. 387, 1149-1157.
247. Reen, R. K., Cadwallader, A., and Perdew, G. H. (2002). The subdomains of the transactivation domain of the aryl hydrocarbon receptor (AhR) inhibit AhR and estrogen receptor transcriptional activity. Arch. Biochem. Biophys. 408, 93-102.
248. Reiner, E. J., Clement, R. E., Okey, A. B., and Marvin, C. H. (2006). Advances in analytical techniques for polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and dioxin-like PCBs. Anal. Bioanal. Chem. 386, 791-806.
249. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992). Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256, 1193-1195.
250. Riddick, D. S., Huang, Y., Harper, P. A., and Okey, A. B. (1994). 2,3,7,8-Tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: Comparative studies of Ah receptor binding, transformation, and induction of CYP1A1. J. Biol. Chem. 269, 12118-12128.
251. Riddick, D. S., Lee, C., Bhathena, A., Timsit, Y. E., Cheng, P. Y., Morgan, E. T., Prough, R. A., Ripp, S. L., Miller, K. K., Jahan, A., et al. (2004). Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab. Dispos. 32 367-375.
252. Rifkind, A. B. (2006). CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metab. Rev. 38, 291-335.
253. Rifkind,A. B.,Gannon,M., andGross, S. S. (1990). Arachidonic acid metabolism by dioxin-induced cytochrome P-450: A new hypothesis on the role of P-450 in dioxin toxicity. Biochem. Biophys. Res. Commun. 172, 1180-1188.
254. Rivera, S. P.,Wang, F., Saarikoski, S. T., Taylor, R. T., Chapman, B., Zhang, R., and Hankinson, O. (2007). A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia. J. Biol. Chem. 282, 10881-10893.
255. Roberts, B. J., and Whitelaw, M. L. (1999). Degradation of the basic helix-loophelix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway. J. Biol. Chem. 274, 36351-36356.
256. Roberts, E. A., Golas, C. L., and Okey, A. B. (1986). Ah receptor mediating induction of aryl hydrocarbon hydroxylase: Detection in human lung by binding of 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin. Cancer Res. 46, 3739-3743.
257. Roberts, E. A., Johnson, K. C., Harper, P. A., and Okey, A. B. (1990). Characterization of the Ah receptor mediating aryl hydrocarbon hydroxylase induction in the human liver cell line Hep G2. Arch. Biochem. Biophys. 276, 442-450.
258. Rothstein, A. (1986). Nonlogical factors in research: Chance and serendipity. Biochem. Cell. Biol. 64, 1055-1065.
259. Rowlanads, J. C., McEwan, I. J., and Gustafsson, J. A. (1996). Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: Direct interactions with basal transcription factors. Mol. Pharmacol. 50, 538-548.
260. Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 21, 51-88.
261. Safe, S. (1997). Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds. Teratog. Carcinog. Mutagen. 17, 285-304.
262. Safe, S., Bandiera, S., Sawyer, T., Zmudzka, B., Mason, G., Romkes, M., Denomme, M. A., Sparling, J., Okey, A. B., and Fujita, T. (1985). Effects of structure on binding to the 2,3,7,8-TCDD receptor protein and AHH induction - halogenated biphenyls. Environ. Health Perspect. 61, 21-33.
263. Safe, S., and McDougal, A. (2002). Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers. Int. J. Oncol. 20, 1123-1128.
264. Safe, S., and Wormke, M. (2003). Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem. Res. Toxicol. 16, 807-816.
265. Safe, S. H. (1986). Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol. 26, 371-399.
266. Safe, S. H. (1998a). Development validation and problems with the toxic equivalency factor approach for risk assessment of dioxins and related compounds. J. Anim. Sci. 76, 134-141.
267. Safe, S. H. (1998b). Hazard and risk assessment of chemical mixtures using the toxic equivalency factor approach. Environ. Health Perspect. 106(Suppl. 4), 1051-1058.
268. Saijo, Y., Sata, F., Yamada, H., Suzuki, K., Sasaki, S., Kondo, T., Gong, Y. Y., Kato, E. H., Shimada, S., Morikawa, M., et al. (2004). Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss. Mol. Hum. Reprod. 10, 729-733.
269. Sanderson, J. T., and Bellward, G. D. (1995). Hepatic microsomal ethoxyresorufin O-deethylase-inducing potency in ovo and cytosolic Ah receptor binding affinity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Comparison of four avian species. Toxicol. Appl. Pharmacol. 132 131-145.
270. Sasaki, S., Kondo, T., Sata, F., Saijo, Y., Katoh, S., Nakajima, S., Ishizuka, M., Fujita, S., and Kishi, R. (2006). Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects. Mol. Hum. Reprod. 12, 77-83.
271. Savas, U., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jefcoate, C. R. (1994). Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression. J. Biol. Chem. 269, 14905-14911.
272. Savouret, J. F., Antenos, M., Quesne, M., Xu, J., Milgrom, E., and Casper, R. F. (2000). 7-ketocholesterol is an endogenous modulator for the Aryl hydrocarbon Receptor. J. Biol. Chem. 20, 20.
273. Schecter, A., Birnbaum, L., Ryan, J. J., and Constable, J. D. (2006). Dioxins: An overview. Environ. Res. 101, 419-428.
274. Schlezinger, J. J., Liu, D., Farago, M., Seldin, D. C., Belguise, K., Sonenshein, G. E., and Sherr, D. H. (2006). A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol. Chem. 387, 1175-1187.
275. Schmidt, J. V., Carver, L. A., and Bradfield, C. A. (1993). Molecular characterization of the murine Ahr gene. Organization, promoter analysis, and chromosomal assignment. J. Biol. Chem. 268, 22203-22209.
276. Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., and Bradfield, C. A. (1996). Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. U. S. A. 93, 6731-6736.
277. Schwarz, M., and Appel, K. E. (2005). Carcinogenic risks of dioxin: Mechanistic considerations. Regul. Toxicol. Pharmacol. 43, 19-34.
278. Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T. (2000). Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 97, 779-782.
279. Shipley, J. M., and Waxman, D. J. (2006). Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methycholanthrene. Toxicol. Appl. Pharmacol. 213, 87-97.
280. Silinskas, K. C., and Okey, A. B. (1975). Protection by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) against mammary tumors and leukemia during prolonged feeding of 7,12-dimethylbenz(a)anthracene to female rats. J. Natl. Cancer Inst. 55, 653-657.
281. Sinal, C. J., and Bend, J. R. (1997). Aryl hydrocarbon receptor-dependent induction of Cyp1a1 by bilirubin in mouse hepatoma Hepa-1c1c7 cells. Mol. Pharmacol. 52, 590-599.
282. Smart, J., and Daly, A. K. (2000). Variation in induced CYP1A1 levels: Relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 10, 11-24.
283. Smith, G. B., Harper, P. A., Wong, J. M., Lam, M. S., Reid, K. R., Petsikas, D., and Massey, T. E. (2001). Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: Impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol. Biomarkers Prev. 10, 839-853.
284. Sogawa, K., Iwabuchi, K., Abe, H., and Fujii-Kuriyama, Y. (1995). Transcriptional activation domains of the Ah receptor and Ah receptor nuclear translocator. J. Cancer Res. Clin. Oncol. 121, 612-620.
285. Sogawa, K., Numayama-Tsuruta, K., Takahashi, T., Matsushita, N., Miura, C., Nikawa, J., Gotoh, O., Kikuchi, Y., and Fujii-Kuriyama, Y. (2004). A novel induction mechanism of the rat CYP1A2 gene mediated by Ah receptor-Arnt heterodimer. Biochem. Biophys. Res. Commun. 318 746-755.
286. Sommer, R. J., Sojka, K. M., Pollenz, R. S., Cooke, P. S., and Peterson, R. E. (1999). Ah receptor and ARNT protein and mRNA concentrations in rat prostate: Effects of stage of development and 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Toxicol. Appl. Pharmacol. 155, 177-189.
287. Song, J., Clagett-Dame, M., Peterson, R. E., Hahn, M. E., Westler, W. M., Sicinski, R. R., and DeLuca, H. F. (2002). A ligand for the aryl hydrocarbon receptor isolated from lung. Proc. Natl. Acad. Sci. U. S. A. 99, 14694-14699.
288. Starr, T. B. (2003). Significant issues raised by meta-analyses of cancer mortality and dioxin exposure. Environ. Health Perspect. 111, 1443-1447.
289. Starr, T. B., Greenlee, W. F., Neal, R. A., Poland, A., and Sutter, T. R. (1999). The trouble with TEFs. Environ. Health Perspect. 107 A492-493.
290. Stone, R. (2007). Epidemiology. Agent Orange's bitter harvest. Science 315, 176-179.
291. Sun, Y. V., Boverhof, D. R., Burgoon, L. D., Fielden, M. R., and Zacharewski, T. R. (2004). Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res. 32, 4512-4523.
292. Sutter, T. R., Guzman, K., Dold, K. M., and Greenlee,W. F. (1991). Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science 254, 415-418.
293. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. (1994). Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem. 269, 13092-13099.
294. Swanson, H. I. (2002). DNA binding and protein interactions of the AHR/ ARNT heterodimer that facilitate gene activation. Chem. Biol. Interact. 141, 63-76.
295. Thomae, T. L., Glover, E., and Bradfield, C. A. (2004). A maternal Ahr null genotype sensitizes embryos to chemical teratogenesis. J. Biol. Chem. 279, 30189-30194.
296. Thurmond, T. S., Silverstone, A. E., Baggs, R. B., Quimby, F.W., Staples, J. E., and Gasiewicz, T. A. (1999). A chimeric aryl hydrocarbon receptor knockout mouse model indicates that aryl hydrocarbon receptor activation in hematopoietic cells contributes to the hepatic lesions induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 158, 33-40.
297. Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., and Gallo, M. A. (1999). Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 274, 510-515.
298. Tian, Y., Rabson, A. B., and Gallo, M. A. (2002). Ah receptor and NF-kappaB interactions: Mechanisms and physiological implications. Chem. Biol. Interact. 141, 97-115.
299. Tiido, T., Rignell-Hydbom, A., Jonsson, B. A., Rylander, L., Giwercman, A., and Giwercman, Y. L. (2007). Modifying effect of the AR gene trinucleotide repeats and SNPs in the AHR and AHRR genes on the association between persistent organohalogen pollutant exposure and human sperm Y: X ratio. Mol. Hum. Reprod. 13, 223-229.
300. Tijet, N., Boutros, P. C., Moffat, I. D., Okey, A. B., Tuomisto, J., and Pohjanvirta, R. (2006). The aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69, 140-153.
301. Tsai, P. C., Huang, W., Lee, Y. C., Chan, S. H., and Guo, Y. L. (2006). Genetic polymorphisms in CYP1A1 and GSTM1 predispose humans to PCBs/ PCDFs-induced skin lesions. Chemosphere 63, 1410-1418.
302. Tsui, H.W., and Okey, A. B. (1981). Rapid vertical tube rotor gradient assay for binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the Ah receptor. Can. J. Physiol. Pharmacol. 59, 927-931.
303. Tuomisto, J. (2005). Does mechanistic understanding help in risk assessment-the example of dioxins. Toxicol. Appl. Pharmacol. 207, 2-10.
304. Tuomisto, J. T., Viluksela, M., Pohjanvirta, R., and Tuomisto, J. (1999). The AH receptor and a novel gene determine acute toxic responses to TCDD: Segregation of the resistant alleles to different rat lines. Toxicol. Appl. Pharmacol. 155, 71-81.
305. Umbreit, T. H., and Gallo, M. A. (1988). Physiological implications of estrogen receptor modulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Lett. 42, 5-14.
306. Umbreit, T. H., Hesse, E. J., Macdonald, G. J., and Gallo, M. A. (1988). Effects of TCDD-estradiol interactions in three strains of mice. Toxicol. Lett. 40, 1-9.
307. US-EPA. (2004). Scientific Highlights from the NAS Review draft of EPA's Dioxin Reassessment. Available at: http://www.epa.gov/ncea/pdfs/dioxin/nas-review. Accessed February 2007.
308. Van Birgelen, A. P., Van der Kolk, J., Fase, K. M., Bol, I., Poiger, H., Brouwer, A., and Van den Berg, M. (1994). Toxic potency of 3,3′,4,4′,5-pentachlorobiphenyl relative to and in combination with 2,3,7,8-tetrachlorodibenzo-p-dioxin in a subchronic feeding study in the rat. Toxicol. Appl. Pharmacol. 127, 209-221.
309. Van den Berg, M., Birnbaum, L. S., Denison, M., De Vito, M., Farland, W., Feeley, M., Fiedler, H., Hakansson, H., Hanberg, A., Haws, L., et al. (2006). The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 93, 223-241.
310. Viluksela, M., Stahl, B. U., Birnbaum, L. S., and Rozman, K. K. (1998). Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo- p-dioxins in rats. II. Biochemical effects. Toxicol. Appl. Pharmacol. 151, 70-78.
311. Waithe, W. I., Michaud, M., Harper, P. A., Okey, A. B., and Anderson, A. (1991). The Ah receptor, cytochrome P450IA1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Biochem. Pharmacol. 41, 85-92.
312. Walisser, J. A., Bunger, M. K., Glover, E., and Bradfield, C. A. (2004a). Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proc. Natl. Acad. Sci. U. S. A. 101, 16677-16682.
313. Walisser, J. A., Bunger, M. K., Glover, E., Harstad, E. B., and Bradfield, C. A. (2004b). Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. J. Biol. Chem. 279 16326-16331.
314. Walisser, J. A., Glover, E., Pande, K., Liss, A. L., and Bradfield, C. A. (2005). Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proc. Natl. Acad. Sci. U. S. A. 102, 17858-17863.
315. Walker, N. J., Crockett, P. W., Nyska, A., Brix, A. E., Jokinen, M. P., Sells, D. M., Hailey, J. R., Easterling, M., Haseman, J. K., Yin, M., et al. (2005). Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds". Environ. Health Perspect. 113, 43-48.
316. Wanner, R., Zober, A., Abraham, K., Kleffe, J., Henz, B. M., and Wittig, B. (1999). Polymorphism at codon 554 of the human Ah receptor: Different allelic frequencies in Caucasians and Japanese and no correlation with severity of TCDD induced chloracne in chemical workers. Pharmacogenetics 9, 777-780.
317. Watanabe, T., Imoto, I., Kosugi, Y., Fukuda, Y., Mimura, J., Fujii, Y., Isaka, K., Takayama, M., Sato, A., and Inazawa, J. (2001). Human arylhydrocarbon receptor repressor (AHRR) gene: Genomic structure and analysis of polymorphism in endometriosis. J. Hum. Genet. 46 342-346.
318. Welch, R. M., Harrison, Y. E., Conney, A. H., Poppers, P. J., and Finster, M. (1968). Cigarette smoking: Stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in human placenta. Science 160 541-542.
319. Whitelaw, M. L., Gottlicher, M., Gustafsson, J. A., and Poellinger, L. (1993). Definition of a novel ligand binding domain of a nuclear bHLH receptor: Co-localization of ligand and hsp90 binding activities within the regulable inactivation domain of the dioxin receptor. EMBO J. 12, 4169-4179.
320. Whitelaw, M. L., Gustafsson, J. A., and Poellinger, L. (1994). Identification of transactivation and repression functions of the dioxin receptor and its basic helix-loop-helix/PAS partner factor Arnt: Inducible versus constitutive modes of regulation. Mol. Cell. Biol. 14, 8343-8355.
321. Whitlock, J. P., Jr. (1999). Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39, 103-125.
322. Wong, J. M., Harper, P. A., Meyer, U. A., Bock, K.W., Morike, K., Lagueux, J., Ayotte, P., Tyndale, R. F., Sellers, E. M., Manchester, D. K., et al. (2001a). Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro. Pharmacogenetics 11, 85-94.
323. Wong, J. M., Okey, A. B., and Harper, P. A. (2001b). Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem. Biophys. Res. Commun. 288, 990-996.
324. Wyde, M. E., Bartolucci, E., Ueda, A., Zhang, H., Yan, B., Negishi, M., and You, L. (2003). The environmental pollutant 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene induces rat hepatic cytochrome P450 2B and 3A expression through the constitutive androstane receptor and pregnane X receptor. Mol. Pharmacol. 64, 474-481.
325. Zhang, D. S., Lin, G. F., Ma, Q. W., and Shen, J. H. (2002). Nonassociation of aryl hydrocarbon receptor genotypes with susceptibility to bladder cancer in Shanghai population. Acta. Pharmacol. Sin. 23, 188-192.
326. Poland, A., and Glover, E. (1973a). 2,3,7,8-Tetrachlorodibenzo-p-dioxin: A potent inducer of -aminolevulinic acid synthetase. Science 179, 476-477.
327. Poland, A., and Glover, E. (1973b). Chlorinated dibenzo-p-dioxins: Potent inducers of delta-aminolevulinic acid synthetase and aryl hydrocarbon hydroxylase. II. A study of the structure-activity relationship. Mol. Pharmacol. 9, 736-747.